London WC1H 9BB
Industry: Medical Laboratories & Research
Full Time Employees: 36
|Dr. Jeremy Rupert Michael Haigh||CEO & Exec. Director||146k||N/A||56|
|Dr. Ian H. Pike||Chief Scientific Officer & Exec. Director||N/A||N/A||N/A|
|Dr. Josef Schwarz||Chief Compliance Officer and Exec. Director||N/A||N/A||N/A|
|Mr. Glenn Barney||VP of Sales & Marketing and VP of Bus. Devel. Us||N/A||N/A||N/A|
|Mr. Malcolm Ward||Chief Technical Officer of London Research Facility||N/A||N/A||N/A|
Proteome Sciences plc, a life sciences company, engages in the research and development of biomarkers. The company delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. It offers PS Biomarker Services to the pharmaceutical, biotechnology, and diagnostics industries for biomarkers discovery, validation, and measurement in clinical trials and in vitro diagnostics. The company also develops various proprietary biomarkers for a range of human diseases, including CNS disorders comprising Alzheimers, Huntingtons, stroke, traumatic brain injury, TSEs, and pain; oncology consisting of lung, breast, esophageal, colorectal cancers, and neuroblastoma; and organ transplant rejection, such as renal and cardiac diseases. In addition, it provides protein tags and assays for spectrometry analysis; and develops isobaric and isotopic reagents under the Tandem Mass Tag brand. Further, the companys biomarker services include proteomics and peptidomics. It operates in the United Kingdom, Germany, and the United States. Proteome Sciences plc was incorporated in 1993 and is headquartered in London, the United Kingdom.
Proteome Sciences plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.